Creative Medical Technology Holdings Inc
General ticker "CELZ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.3M
Creative Medical Technology Holdings Inc does not follow the US Stock Market performance with the rate: -32.4%.
Estimated limits based on current volatility of 4.2%: low 2.05$, high 2.22$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.51$, 4.78$]
- 2024-12-30 to 2025-12-30 estimated range: [0.70$, 2.44$]
Financial Metrics affecting the CELZ estimates:
- Negative: Non-GAAP EPS, $ of -3.71 <= 0.10
- Negative: Operating profit margin, % of -99.84 <= 1.03
- Negative: Operating cash flow per share per price, % of -55.72 <= 2.35
- Negative: negative Net income
Short-term CELZ quotes
Long-term CELZ plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.09MM | $0.09MM | $0.01MM |
| Operating Expenses | $3.21MM | $10.33MM | $5.63MM |
| Operating Income | $-3.13MM | $-10.24MM | $-5.62MM |
| Non-Operating Income | $22.34MM | $0.10MM | $0.33MM |
| Interest Expense | $4.28MM | $0.00MM | $0.00MM |
| R&D Expense | $0.11MM | $6.27MM | $1.97MM |
| Income(Loss) | $19.21MM | $-10.14MM | $-5.29MM |
| Profit(Loss) | $19.21MM | $-10.14MM | $-5.29MM |
| Stockholders Equity | $10.22MM | $15.86MM | $10.34MM |
| Inventory | $0.01MM | $0.01MM | $0.01MM |
| Assets | $11.27MM | $19.19MM | $10.72MM |
| Operating Cash Flow | $-2.22MM | $-7.80MM | $-8.03MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.10MM |
| Investing Cash Flow | $0.00MM | $-10.08MM | $3.45MM |
| Financing Cash Flow | $12.84MM | $15.47MM | $-0.27MM |
| Earnings Per Share* | $57.32 | $-9.19 | $-3.76 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.